Display options
Cite
Kim EL, Sorokin M, Kantelhardt SR, et al. Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma. Cancers (Basel). 2020;12(2)doi: 10.3390/cancers12020520.
Kim, E. L., Sorokin, M., Kantelhardt, S. R., Kalasauskas, D., Sprang, B., Fauss, J., Ringel, F., Garazha, A., Albert, E., Gaifullin, N., Hartmann, C., Naumann, N., Bikar, S. E., Giese, A., & Buzdin, A. (2020). Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma. Cancers, 12(2), . https://doi.org/10.3390/cancers12020520
Kim, Ella L, et al. "Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma." Cancers vol. 12,2 (2020). doi: https://doi.org/10.3390/cancers12020520
Kim EL, Sorokin M, Kantelhardt SR, Kalasauskas D, Sprang B, Fauss J, Ringel F, Garazha A, Albert E, Gaifullin N, Hartmann C, Naumann N, Bikar SE, Giese A, Buzdin A. Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma. Cancers (Basel). 2020 Feb 24;12(2). doi: 10.3390/cancers12020520. PMID: 32102350; PMCID: PMC7072286.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2020 Feb 24;12(2). doi: 10.3390/cancers12020520.

Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma.

Cancers

Ella L Kim, Maxim Sorokin, Sven Rainer Kantelhardt, Darius Kalasauskas, Bettina Sprang, Julian Fauss, Florian Ringel, Andrew Garazha, Eugene Albert, Nurshat Gaifullin, Christian Hartmann, Nicole Naumann, Sven-Ernö Bikar, Alf Giese, Anton Buzdin

Affiliations

  1. Clinic for Neurosurgery, Laboratory of Experimental Neurooncology, Johannes Gutenberg University Medical Centre, Langenbeckstrasse 1, 55124 Mainz, Germany.
  2. Institute of Personalized Medicine, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
  3. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.
  4. Omicsway Corp., 340 S Lemon Ave, 6040, Walnut, CA 91789, USA.
  5. Clinic for Neurosurgery, Johannes Gutenberg University Medical Centre, Langenbeckstrasse 1, 55124 Mainz, Germany.
  6. Department of Pathology, Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
  7. Department of Neuropathology, Institute of Pathology, Hannover Medical School, 30625 Hannover, Germany.
  8. StarSEQ GmbH, Joh.-Joachim-Becher-Weg 30a, 55128 Mainz, Germany.
  9. OrthoCentrum Hamburg, Hansastrasse 1, 20149 Hamburg, Germany.
  10. Oncobox Ltd., 121205 Moscow, Russia.
  11. Moscow Institute of Physics and Technology, 141701 Moscow Region, Russia.

PMID: 32102350 PMCID: PMC7072286 DOI: 10.3390/cancers12020520

[No abstract available.]

Keywords: gene expression; glioblastoma; glioblastoma stem cells; molecular pathways; recurrent glioblastoma; target anti-cancer therapy; transcriptomics

References

  1. Nat Rev Clin Oncol. 2018 Jul;15(7):422-442 - PubMed
  2. Cancer Cell. 2010 Jan 19;17(1):98-110 - PubMed
  3. Nature. 2004 Nov 18;432(7015):396-401 - PubMed
  4. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14 - PubMed
  5. Cell. 2019 Aug 8;178(4):835-849.e21 - PubMed
  6. Cancers (Basel). 2018 Sep 29;10(10): - PubMed
  7. J Immunol Methods. 2009 Aug 15;347(1-2):70-8 - PubMed
  8. Methods Mol Biol. 2020;2063:207-234 - PubMed
  9. Front Oncol. 2019 Jan 04;8:658 - PubMed
  10. Mol Cancer Ther. 2017 Jun;16(6):1177-1186 - PubMed
  11. Oncotarget. 2017 Jul 28;8(48):83768-83780 - PubMed
  12. Am J Cancer Res. 2015 Feb 15;5(3):945-55 - PubMed
  13. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):346-354 - PubMed
  14. Oncotarget. 2015 Sep 29;6(29):27227-38 - PubMed
  15. Genome Biol. 2014;15(12):550 - PubMed
  16. Cancer Cell. 2012 Jan 17;21(1):11-24 - PubMed
  17. Exp Hematol Oncol. 2018 Sep 6;7:21 - PubMed
  18. Oncotarget. 2014 Oct 30;5(20):10198-205 - PubMed
  19. Stem Cells Int. 2016;2016:6809105 - PubMed
  20. N Engl J Med. 2005 Mar 10;352(10):997-1003 - PubMed
  21. Cancer Cell. 2015 Sep 14;28(3):318-28 - PubMed
  22. Nat Biotechnol. 2014 Sep;32(9):903-14 - PubMed
  23. Oncotarget. 2015 Oct 6;6(30):29347-56 - PubMed
  24. Nucleic Acids Res. 2013 Jan;41(Database issue):D353-7 - PubMed
  25. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6 - PubMed
  26. Science. 2014 Jun 20;344(6190):1396-401 - PubMed
  27. Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7 - PubMed
  28. Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2): - PubMed
  29. Oncotarget. 2015 May 20;6(14):12094-109 - PubMed
  30. Cancers (Basel). 2011 Aug 10;3(3):3242-78 - PubMed
  31. Expert Rev Neurother. 2015;15(7):741-52 - PubMed
  32. Cell. 2013 Oct 10;155(2):462-77 - PubMed
  33. Neuro Oncol. 2017 Nov 29;19(12):1599-1606 - PubMed
  34. Cell Cycle. 2017 Oct 2;16(19):1810-1823 - PubMed
  35. Methods Mol Biol. 2020;2063:189-206 - PubMed
  36. Mol Syst Biol. 2016 Nov 25;12(11):889 - PubMed
  37. Curr Oncol. 2015 Aug;22(4):e273-81 - PubMed
  38. Nucleic Acids Res. 2009 Jan;37(Database issue):D674-9 - PubMed
  39. PLoS One. 2017 Dec 21;12(12):e0190152 - PubMed
  40. Methods Mol Biol. 2020;2063:235-255 - PubMed
  41. Semin Cancer Biol. 2018 Dec;53:110-124 - PubMed
  42. Bioinformatics. 2013 Jan 1;29(1):15-21 - PubMed
  43. Nat Genet. 2017 May;49(5):780-788 - PubMed
  44. Cancer Cell. 2015 Nov 9;28(5):666-676 - PubMed
  45. Nature. 2008 Oct 23;455(7216):1061-8 - PubMed
  46. Neuro Oncol. 2018 Jun 18;20(7):873-884 - PubMed
  47. Stem Cells Int. 2016;2016:7849890 - PubMed
  48. Oncogene. 2016 Nov 10;35(45):5819-5825 - PubMed
  49. Sci Rep. 2016 Feb 01;6:20200 - PubMed
  50. Semin Cancer Biol. 2020 Feb;60:311-323 - PubMed
  51. Cancer Cell. 2006 Mar;9(3):157-73 - PubMed
  52. Sci Data. 2019 Apr 23;6(1):36 - PubMed
  53. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  54. Hum Genome Var. 2015 Apr 02;2:15009 - PubMed
  55. N Engl J Med. 2005 Mar 10;352(10):987-96 - PubMed
  56. Oncogene. 2019 Apr;38(15):2706-2721 - PubMed
  57. Science. 2014 Jan 10;343(6167):189-193 - PubMed
  58. Genes Dev. 2015 Jun 15;29(12):1203-17 - PubMed
  59. Clin Cancer Res. 2017 Jul 15;23(14):3700-3710 - PubMed

Publication Types

Grant support